Biomanufacturing: Ready to Take Off  

Engineered bacteria used to target tumors, waste gases converted into proteins, seawater used to produce plastics, and fungi utilized to create leather…  

As one of the six key future industries identified in the 11th Five-Year Plan, biomanufacturing is accelerating its transition from the laboratory to industrial scale. It has risen to the status of a national strategic priority and has become the core driver of new productive forces.  

McKinsey predicts that by 2050, the value of biomanufacturing will reach $30 trillion, accounting for one-third of the global manufacturing sector. Additionally, 60% of existing products could be produced through biotechnological methods. Driven by national strategic guidance, technological breakthroughs, and market demand, biomanufacturing is entering a golden age, heralding a transformative era in human production and lifestyle.  

As the innovation hub of the Guangdong-Hong Kong-Macao Greater Bay Area, Shenzhen is committed to implementing national strategies and striving to become a global leader in the field of synthetic biomanufacturing.  

On December 2nd, the 6th Biomanufacturing Industry Conference, themed “Synthetic Biomanufacturing: Reshaping Human Life,” was successfully held at the Shenzhen Guangming Cultural and Art Center.